首页> 外文OA文献 >Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

【2h】

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

机译：通过结合抗CD123和抗CD19嵌合抗原受体T细胞治疗CD19靶向免疫疗法后发生的白血病抗原丢失复发

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marco Ruella; David M Barrett; Saad S Kenderian; Olga Shestova; Ted J Hofmann; John Scholler; Simon F Lacey; Jan J Melenhorst; Farzana Nazimuddin; Jessica Perazzelli; David A Christian; Christopher A Hunter; David L Porter; Carl H June; Stephan A Grupp; Saar Gill;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells [J] . Marco Ruella, David M Barrett, Saad S Kenderian, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：通过结合抗CD123和抗CD19嵌合抗原受体T细胞治疗CD19靶向免疫疗法后发生的白血病抗原丢失复发
2. Immunotherapy with Autologous Anti-CD19 Chimeric Antigen Receptor T Cells Followed By Allogeneic Hematopoietic Stem Cell Transplantation Has Remarkably Improved Leukemia-Free Survival in Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia [J] . Zhao Yan-Li, Wu Tong, Liu De-Yan, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：自体抗CD19嵌合抗原受体T细胞的免疫治疗，随后进行异基因造血干细胞移植，显着改善了难治性/复发性B细胞急性淋巴细胞白血病中的无白血病生存率。
3. Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases [J] . Zhang Jian, Yang Fei, Qiu Hui-Ying, Leukemia and lymphoma . 2019,第5a6期

机译：抗CD19嵌合抗原受体T细胞用于治疗复发或难治性E2A-PBX1阳性急性淋巴细胞白血病：3例报告
4. Modification of T lymphocytes with lentiviral vectors for expression of anti-CD19 chimeric antigen receptor (CAR) [C] . Virginia Picanco-Castro, Pablo Moco, Daianne MC Fantacini, Scale-up and manufacturing of cell-based therapies V . 2017

机译：用慢病毒载体修饰T淋巴细胞以表达抗CD19嵌合抗原受体（CAR）
5. Targeting the Disialoganglioside GD2 with Chimeric Antigen Receptor T Cells for Immunotherapy in Diffuse Midline Gliomas, and Exploration of Neuron-OPC Synaptic Connectivity in the Context of Adaptive Myelination [D] . Mount, Christopher W. 2020

机译：用嵌合抗原受体T细胞靶向Diaialoganglioside GD2，用于在弥漫性中线胶质瘤中的免疫疗法，以及在适应性髓鞘中的背景下探索神经元-Popaptic连通性
6. Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells [O] . Marco Ruella, David M Barrett, Saad S Kenderian, 2015

机译：通过抗CD123和抗CD19嵌合抗原受体T细胞的组合治疗CD19靶向免疫疗法后发生的白血病抗原丢失复发
7. The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis [O] . Hui Zhou, Yuling Luo, Sha Zhu, 2018

机译：抗CD19 / CD20嵌合抗原受体T细胞免疫疗法在复发或难治性B细胞恶性肿瘤中的疗效和安全性：META分析

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

著录项

引文网络

相似文献

相关主题

期刊订阅